These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 26514750)

  • 21. Clinical Utility of Combined Optical Coherence Tomography and Near-Infrared Spectroscopy for Assessing the Mechanism of Very Late Stent Thrombosis.
    Ino Y; Kubo T; Kameyama T; Shimamura K; Terada K; Matsuo Y; Kitabata H; Shiono Y; Kashiwagi M; Kuroi A; Maniwa N; Ota S; Ozaki Y; Tanaka A; Hozumi T; Akasaka T
    JACC Cardiovasc Imaging; 2018 May; 11(5):772-775. PubMed ID: 29361480
    [No Abstract]   [Full Text] [Related]  

  • 22. Subclinical very late thrombus formation inside and outside the everolimus-eluting stent implanted 3 years prior in a patient with provoked coronary spasms.
    Ito S; Ohmori H
    Cardiovasc Interv Ther; 2017 Jan; 32(1):72-76. PubMed ID: 26660342
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Very late scaffold thrombosis: insights from optical coherence tomography and histopathology.
    Joner M; Nicol P; Rai H; Richter H; Foin N; Ng J; Cuesta J; Rivero F; Serrano R; Alfonso F
    EuroIntervention; 2018 Apr; 13(18):e2169-e2173. PubMed ID: 29155382
    [No Abstract]   [Full Text] [Related]  

  • 24. Quantitative optical coherence tomography analysis for late in-stent restenotic lesions.
    Fu Q; Suzuki N; Kozuma K; Miyagawa M; Nomura T; Kawashima H; Shiratori Y; Ishikawa S; Kyono H; Isshiki T
    Int Heart J; 2015; 56(1):13-7. PubMed ID: 25503658
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Very early tissue coverage after drug-eluting stent implantation: an optical coherence tomography study.
    Takahara M; Kitahara H; Nishi T; Miura K; Miyayama T; Sugimoto K; Nakayama T; Fujimoto Y; Kobayashi Y
    Int J Cardiovasc Imaging; 2017 Jan; 33(1):25-30. PubMed ID: 27601229
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incomplete stent apposition and very late stent thrombosis after everolimus eluting stent implantation and dual antiplatelet therapy interruption. A case of OCT guided therapy.
    Gatto P; Dumonteil N; Boudou N; Van Rothem J; Lhermusier T; Bartorelli A; Carrié D
    Int J Cardiol; 2015 Feb; 180():52-4. PubMed ID: 25438210
    [No Abstract]   [Full Text] [Related]  

  • 27. Late stent thrombosis after the use of a bioresorbable vascular scaffold for the treatment of in-stent restenosis.
    Lee WC; Fang HY; Fang CY
    Coron Artery Dis; 2016 Dec; 27(8):709-710. PubMed ID: 27379437
    [No Abstract]   [Full Text] [Related]  

  • 28. Very late stent thrombosis and longitudinal stent deformation.
    Buysschaert I; Ughi GJ; Adriaenssens T; Vermeersch P
    Acta Cardiol; 2017 Apr; 72(2):216-217. PubMed ID: 28597802
    [No Abstract]   [Full Text] [Related]  

  • 29. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
    Yamaguchi H; Arikawa R; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
    Cardiovasc Revasc Med; 2015; 16(1):32-5. PubMed ID: 25617940
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mechanisms of atherothrombosis and vascular response to primary percutaneous coronary intervention in women versus men with acute myocardial infarction: results of the OCTAVIA study.
    Guagliumi G; Capodanno D; Saia F; Musumeci G; Tarantini G; Garbo R; Tumminello G; Sirbu V; Coccato M; Fineschi M; Trani C; De Benedictis M; Limbruno U; De Luca L; Niccoli G; Bezerra H; Ladich E; Costa M; Biondi Zoccai G; Virmani R;
    JACC Cardiovasc Interv; 2014 Sep; 7(9):958-68. PubMed ID: 25129664
    [TBL] [Abstract][Full Text] [Related]  

  • 31. First-in-man study evaluating the safety and efficacy of a second generation biodegradable polymer sirolimus-eluting stent in the treatment of patients with de novo coronary lesions: clinical, Angiographic, and OCT outcomes of CREDIT-1.
    Wang G; Sun Z; Jin Q; Xu K; Li Y; Wang X; Ma Y; Liu H; Zhao X; Wang B; Deng J; Guan S; Ge M; Wang X; Xu B; Han Y
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():744-51. PubMed ID: 25630447
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Histopathologically confirmed very late stent thrombosis associated with stent fracture after implantation of first-generation drug eluting stent.
    Konishi T; Funayama N; Yamamoto T; Hotta D; Kobayashi Y; Komoriyama H; Kato Y; Omote K; Sato T; Kamiya K; Nagai T; Tanaka S; Anzai T
    Cardiol J; 2020; 27(2):204-205. PubMed ID: 32463109
    [No Abstract]   [Full Text] [Related]  

  • 33. Characteristics of Earlier Versus Delayed Presentation of Very Late Drug-Eluting Stent Thrombosis: An Optical Coherence Tomographic Study.
    Lee SY; Ahn JM; Mintz GS; Hur SH; Choi SY; Kim SW; Cho JM; Hong SJ; Kim JW; Hong YJ; Lee SG; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Park SJ; Hong MK
    J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28411245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neointimal coverage of zotarolimus-eluting stent at 1, 2, and 3 months' follow-up: an optical coherence tomography study.
    Hashikata T; Tojo T; Namba S; Kitasato L; Hashimoto T; Kameda R; Shimohama T; Yamaoka-Tojo M; Ako J
    Heart Vessels; 2016 Feb; 31(2):206-11. PubMed ID: 25362579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early Collapse of a Magnesium Bioresorbable Scaffold.
    Cubero-Gallego H; Vandeloo B; Gomez-Lara J; Romaguera R; Roura G; Gomez-Hospital JA; Cequier A
    JACC Cardiovasc Interv; 2017 Sep; 10(18):e171-e172. PubMed ID: 28935085
    [No Abstract]   [Full Text] [Related]  

  • 36. The Absorb Limits.
    Gómez Menchero AE; Camacho Freire SJ; Díaz Fernández JF; Roa Garrido J; León Jiménez J; Cardenal Piris R
    J Invasive Cardiol; 2016 Oct; 28(10):E122-E123. PubMed ID: 27705895
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Very Late Stent Thrombosis 11 Years after Implantation of a Drug-Eluting Stent.
    Liou K; Jepson N
    Tex Heart Inst J; 2015 Oct; 42(5):487-90. PubMed ID: 26504449
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of stent type and of duration of dual antiplatelet therapy in patients with chronic kidney disease undergoing percutaneous coronary interventions. Is bare metal stent implantation still a justifiable choice? A post-hoc analysis of the all comer PRODIGY trial.
    Crimi G; Leonardi S; Costa F; Adamo M; Ariotti S; Valgimigli M
    Int J Cardiol; 2016 Jun; 212():110-7. PubMed ID: 27038714
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal threshold of postintervention minimum stent area to predict in-stent restenosis in small coronary arteries: An optical coherence tomography analysis.
    Matsuo Y; Kubo T; Aoki H; Satogami K; Ino Y; Kitabata H; Taruya A; Nishiguchi T; Teraguchi I; Shimamura K; Shiono Y; Orii M; Yamano T; Tanimoto T; Yamaguchi T; Hirata K; Tanaka A; Akasaka T
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E9-E14. PubMed ID: 26268150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Asymptomatic Large Thrombus Formation in Drug-Eluting Stent 2 Days After Primary Percutaneous Coronary Intervention in ST-Segment Elevation Myocardial Infarction Patient.
    Okamoto N; Vengrenyuk Y; Baber U; Kini AS
    JACC Cardiovasc Interv; 2017 Dec; 10(23):2461-2463. PubMed ID: 28866039
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.